ENAGenomicsDepartment of Infectious Diseases, The Second Affiliated Hospital of Chongqing Medical Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA1309012Dysbiosis of gut microbiota and metabolic disturbances are implicated in the progression of hepatitis B virus (HBV)-related cirrhosis. However, the mechanisms underlying these associations, particularly in patients with undetectable HBV-DNA following antiviral therapy but persistent liver enzyme abnormalities, remain poorly understood. This study aimed to characterize the gut microbiota and metabolic profiles in this patient population to elucidate potential mechanisms and identify biomarkers.ENAfalseGut microbiota and metabolite profiles in HBV cirrhosis with persistent liver enzyme abnormalities2025-09-082025-09-08PRJNA1309012